Covestor’s MiMedx Group MDXG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2K Buy
394
+318
+418% +$1.16K ﹤0.01% 1982
2026
Q1
$0 Buy
76
+37
+95% +$186 ﹤0.01% 2568
2025
Q4
$0 Sell
39
-14
-26% -$98 ﹤0.01% 2537
2025
Q3
$0 Buy
53
+2
+4% +$14 ﹤0.01% 2548
2025
Q2
$0 Buy
51
+9
+21% +$60 ﹤0.01% 2515
2025
Q1
$0 Sell
42
-194
-82% -$1.62K ﹤0.01% 2518
2024
Q4
$2K Buy
236
+182
+337% +$1.42K ﹤0.01% 1901
2024
Q3
$0 Sell
54
-4,945
-99% -$32.8K ﹤0.01% 2519
2024
Q2
$35K Buy
4,999
+725
+17% +$5.1K 0.02% 996
2024
Q1
$33K Sell
4,274
-202
-5% -$1.62K 0.02% 1037
2023
Q4
$39K Buy
+4,476
New +$32.8K 0.03% 959

Other funds holding MDXG

Covestor's MDXG Position: Q2 2026 in Review

Covestor increased its MiMedx Group (MDXG) stake by 418% in Q2 2026, buying an estimated $1.16K and bringing the position to 394 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #1982.

Covestor first reported a position in MDXG in Q4 2023 and has held it in 11 quarters since. The position peaked at $39K in Q4 2023. 226 funds tracked by Wall St. Rank hold MDXG as of Q2 2026.

  • Covestor held 394 shares of MiMedx Group worth $2K as of Q2 2026.
  • Covestor bought 318 MiMedx Group shares in Q2 2026, an estimated $1.16K.
  • MiMedx Group made up ﹤0.01% of Covestor's portfolio in Q2 2026, its #1982 holding.
  • Covestor first reported a position in MiMedx Group in Q4 2023 and has held it in 11 quarters since.
  • Covestor's MiMedx Group position peaked at $39K in Q4 2023.
  • 226 funds tracked by Wall St. Rank held MiMedx Group as of Q2 2026.

Based on Covestor's 13F filing for Q2 2026, filed 7 Aug 2026.